Do patients care about accelerated approval drugs?
World of DTC Marketing
MARCH 23, 2022
85% of accelerated approvals from 2010 to 2020 were for oncology indications. of approvals), cancer (35.6%), and other rare diseases (24.7%). Since then, accelerated Approval has shifted focus to oncology drugs.
Let's personalize your content